Italy was one of the precursors of the implementation of anti-counterfeit measures of drugs. The “Bollinos”, a more and more recurring word in the industry were the labels that the Italians first used to introduce the unique serialized code.
While this system has served as a basis and inspiration for the reform of Directive 20122/62/EU, it is a simple and reliable solution for the detection of counterfeit drugs, while being effective regarding consumer safety.
These labels must comply with special requirements for the Italian market, as articulated by the Ministry of Health, so that verification can be carried out from the very point of sale.
The “Bollino” or label must include the AIC (Authorized Identification Code) by the Italian Agency of Drugs for commercialization, the name of the drug, the representative /owner of the brand or the legal representative, and the progressive identification code of each case.
All information contained in the Bollino, which is serialized with a unique code, is stored in a Central Data Base that records the entire route of the drug.
Each area that interacts with the drug must communicate online, all the movements to this Central Data Base, as well as check the authenticity and the data at the moment of its reception.
The Italian Federation of Associations of Drug Visitors (FEDAIISF) claims that the black market of counterfeit or contraband drugs, ranges between 50 and 200 billion Euros, and is responsible for the death of about 200,000 worldwide.